Protein binder design
Design compact proteins against a specified target surface, then connect sequence optimization, refolding, and interface review.
More protein design workflows
Tools for protein binder design
Use these methods to prepare inputs, run the core analysis, inspect outputs, and validate the evidence described in this workflow.
BindCraft
Generate and optimize de novo protein binders
RFdiffusion3
Generate target-conditioned binder backbones
BoltzGen
Generate protein binders against a target
ProteinMPNN
Optimize binder sequences for generated backbones
ESM-IF1
Generate alternative structure-conditioned sequences
ESMFold
Refold designed sequences for structural comparison
ProLIF
Summarize designed interface interactions
PDBsum
Review interface contacts and structural context
MolProbity
Review clashes and stereochemical geometry
Protein stability prediction
Estimate sequence-level stability signals
NetSolP-1.0
Estimate sequence-level solubility
Aggrescan3D
Inspect structure-based aggregation-prone regions
What is protein binder design?
Protein binder design is the process of creating proteins intended to recognize a specified molecular target or surface. Structure-based methods generate a binder backbone in the context of a target, optimize its sequence, and assess whether the candidate is predicted to fold and maintain the designed interface. The computational result is a prioritized binder hypothesis, not evidence of affinity, specificity, or biological activity.
Target preparation and epitope choice strongly influence the search. Missing loops, glycans, cofactors, oligomeric partners, or an incorrect conformational state can make a technically successful design irrelevant to the biological target.
Generate structural and sequence diversity, then inspect interface contacts, buried surface, clashes, binder self-folding, aggregation risk, and alternatives across the target surface. Prospective experiments must measure affinity and specificity rather than relying on model confidence.
When to use protein binder design
Binder design begins with a target surface and a binding assay:
- A defined epitope or hotspot can guide generation.
- A compact protein binder is acceptable for the intended application.
- You can measure affinity and specificity against relevant controls.
Strengths and limitations
Target-conditioned generation can propose binder backbones around a chosen surface, followed by sequence redesign and independent refolding. Reviewing interface geometry alongside binder-only stability helps distinguish a plausible complex from a binder that depends on the target to appear folded.
A predicted interface can be blocked by glycans, membrane orientation or the target native assembly. Interface confidence is not a measured dissociation constant. BindCraft on ProteinIQ uses a different relaxation and filtering path from the published Rosetta pipeline, so its published hit rates should not be carried over.
Protein binder design methods
Binder generators optimize a candidate in the context of a target structure and often incorporate predicted complex confidence. Hotspot constraints can focus the interface, but overly narrow constraints may reduce diversity or favor strained solutions.
Sequence redesign and independent refolding test whether a generated interface can be supported by a plausible binder sequence. They do not establish that the target and binder will associate under experimental conditions.
Applications of protein binder design
A designed binder can test whether a selected target surface is accessible to a compact protein interface. Alternative binder topologies and hotspot choices provide competing hypotheses about how to engage that surface.
Binder design is also useful for building assay reagents, but a predicted interface must survive expression, monodispersity and specificity tests. Compare candidates across sequence families and target states rather than retaining only the highest model confidence.
How to run protein binder design online
The featured workflow chains BindCraft generation to sequence redesign, binder refolding and geometry review. Its BindCraft implementation follows the ProteinIQ tool documentation, including its distinct relaxation path.
- Prepare the target. Supply a PDB of the relevant assembly and check glycans, cofactors and membrane orientation near the proposed epitope.
- Define the interface. Record hotspot residues, binder size and any exclusion regions before generation.
- Generate binders. Run BindCraft and retain its native interface confidence, accepted models and rejected candidates.
- Redesign sequences. Use ProteinMPNN on accepted binder backbones while preserving the target and hotspot context.
- Refold and check geometry. Use ESMFold for binder-only folding review. Inspect modeled structures with MolProbity.
- Measure binding. Select a diverse panel and test affinity, specificity, expression and relevant functional response.
How to interpret protein binder design results
Inspect target relevance, epitope coverage, interface contacts, buried surface, clashes, shape complementarity, binder self-confidence, refold agreement, sequence diversity, solubility, and aggregation risk.
Experiments should include expression and monodispersity checks, quantitative affinity, specificity against related and unrelated proteins, competition or epitope mapping, and a function-relevant assay.
Experimental validation and handoff
Keep the exact target structure, assembly, hotspot definition, generation settings, sequence variants, and rejected candidates. Measure affinity, specificity, and function experimentally.
Keep the target assembly, hotspot definition, binder-only fold and complex model together. Quantitative affinity and off-target controls determine whether a structural proposal becomes a usable binder.
How protein binder design works
Generate target-conditioned binders with BindCraft, redesign sequences with ProteinMPNN, refold them, and inspect geometry.
- Prepare target. Prepare the biologically relevant target structure, assembly, cofactors, glycans, and conformational state.
- Define epitope. Define the intended epitope or hotspot residues and binder size, topology, and chemistry constraints.
- Generate binders. Generate diverse target-conditioned backbones and multiple sequence variants for accepted designs.
- Validate models. Review interface geometry, refold agreement, clashes, buried surface, solubility, and aggregation risk.
- Measure binding. Express selected candidates and measure affinity, specificity, competition, and biological function.
Inputs and outputs
Check formats before running, then inspect and download the result from every workflow step.
Inputs
Design input
PDBFASTAJSONTXTA target protein PDB with the intended biological assembly and optional hotspot residues.
Outputs
Design and review outputs
PDBFASTACSVJSONBinder backbone PDB files, designed FASTA sequences, refolded models, interface scores, and review results.
Frequently asked questions
Favor a solvent-accessible surface connected to the intended mechanism and available in the relevant biological state. Avoid surfaces dominated by unresolved loops, flexible glycans, crystal contacts, or regions inaccessible in the full assembly.
Design or counter-screen against the states that matter to the mechanism. A binder optimized for one structure may fail to recognize another state or may unintentionally stabilize a conformation with the wrong biological effect.
Set minimum evidence for both rather than optimizing one in isolation. Very strong predicted target contacts are not useful if the same surface chemistry is likely to bind related proteins or common assay components.
Include close homologs, relevant paralogs, the unbound scaffold or tags used in the assay, and unrelated proteins that reveal nonspecific binding. The exact panel should reflect the intended biological and experimental context.
For experimentally characterized VHH or scFv binders, DuneX publishes $5,000 for a pilot campaign, up to $15,000 for its Standard package after the success milestone, and up to $25,000 for Premium. The packages include library screening, delivery of binding clones, and affinity characterization; broader de novo miniprotein programs remain quote-based.
Target and antigen preparation, library strategy, epitope constraints, affinity goal, counter-selection, clone count, expression and purification, developability work, functional assays, optimization rounds, and success milestones drive the final binder-design cost.
ProteinIQ self-service starts at $29 per month for academic Plus and $99 per month for commercial Pro, with the configured run quoted in credits before submission. A done-for-you protein binder design project is scoped separately; synthesis, expression, and experimental assays are included only when the project quote explicitly says so.
AI answers from our docs. No sign-in needed.
Run your first analysis today
Start with 200 free credits and no installs. Upgrade when your project needs more compute.